SenesTech Announces 2021 First Quarter Financial and Operational Results
Revenues Up 138 Percent from the First Quarter in 2020
News provided by
Share this article
Share this article
PHOENIX, May 13, 2021 /PRNewswire/ SenesTech, Inc. (NASDAQ: SNES), (www.senestech.com) the rodent fertility control experts and inventors of the first and only registered rat contraceptive, ContraPest
® announced today revenues for the first quarter in 2021 were up 138 percent from the same period a year ago while operating expenses have been reduced by 20 percent. During the past year, SenesTech has transitioned from a science-based research company to a solutions-based, environmentally responsible commercial company providing a new and proven tool to pest control management for the 21
/PRNewswire/ LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration.
Operator
Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics First Quarter 2021 Conference Call. At this time, I would like to inform you that this call is being recorded and that all participants are in a listen-only mode. At the company s request, we will open the call for questions-and-answers after the presentation.
I will now like to turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.
Diane Weiser
Senior Vice President of Corporate Communications & Investor Relations
Good afternoon, and thanks for joining us on the call today. Robert Blum, our President and Chief Executive Officer, will kick off the call with an overview of the quarter and recent developments. Then Fady Malik, our EVP of Research and Development, will provide an update on omecamtiv mecarbil, including progress following a recent meeting with FDA and what to expect from upcoming analyses from GALACTIC-H
the First Quarter Ended March 31, 2021 For Immediate Release PORTLAND, Maine - May 6, 2021 - ImmuCell Corporation (Nasdaq: ICCC) ( ImmuCell or the Company ), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2021 after the market closes on Thursday, May 13, 2021. The Company has scheduled a conference call the next morning, Friday, May 14, 2021, at 9:00 AM ET to review the results as well as its recent equity raise. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET. A teleconference replay of the call will be available for seven days at (877) 344-7529 (toll free) or (412) 317-0088 (international), utilizing confirmation #10154478.
SenesTech to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET
News provided by
Share this article
Share this article
PHOENIX, May 5, 2021 /PRNewswire/ SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its first quarter 2021, ended March 31, 2021, after the market close on Thursday, May 13, 2021. The Company has scheduled a conference call that same day, Thursday, May 13, 2021, at 5:00 pm ET, to review the results.
First Quarter 2021 Conference Call Details
Date and Time: Thursday, May 13, 2021 at 5:00 pm ET